144 related articles for article (PubMed ID: 20799514)
1. Clinicopathological factors associated to HER-2 status in a hospital-based sample of breast cancer patients in Puerto Rico.
Ortiz AP; Frías O; González-Keelan C; Suárez E; Capó D; Pérez J; Cabanillas F; Mora E
P R Health Sci J; 2010 Sep; 29(3):265-71. PubMed ID: 20799514
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico.
Ortiz AP; Frías O; Pérez J; Cabanillas F; Martínez L; Sánchez C; Capó-Ramos DE; González-Keelan C; Mora E; Suárez E
Cancer Med; 2013 Jun; 2(3):343-50. PubMed ID: 23930211
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of steroid receptors and HER 2/neu in breast cancer biopsies of women living in Puerto Rico.
Colón E; Reyes JS; González Keelan C; Climent-Peris C
P R Health Sci J; 2002 Dec; 21(4):299-303. PubMed ID: 12572236
[TBL] [Abstract][Full Text] [Related]
4. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of breast and ovarian cancer subtypes in Hispanic populations from Puerto Rico.
Rodriguez-Velazquez A; Velez R; Lafontaine JC; Colon-Echevarria CB; Lamboy-Caraballo RD; Ramirez I; Mendoza A; Casbas-Hernandez P; Armaiz-Pena GN
BMC Cancer; 2018 Nov; 18(1):1177. PubMed ID: 30482165
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
7. Changing frequency of equivocal HER-2/neu scores and factors predictive of negative HER 2/neu fluorescent in situ hybridisation in invasive carcinomas of the breast.
Boulos F; Farra CG; Saad Aldin EM; Masaad C; Hassoun Y; Fedda F; Doumiati H; Tawil AN; Nasser Z; Nahleh Z; Tfayli A
J Clin Pathol; 2014 Mar; 67(3):204-9. PubMed ID: 24108431
[TBL] [Abstract][Full Text] [Related]
8. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.
Gabos Z; Thoms J; Ghosh S; Hanson J; Deschênes J; Sabri S; Abdulkarim B
Breast Cancer Res Treat; 2010 Nov; 124(1):187-94. PubMed ID: 20814819
[TBL] [Abstract][Full Text] [Related]
9. Expression of Basal-like Biomarkers in Triple Negative Invasive Breast Carcinoma in Puerto Rico.
Agosto-Arroyo E; Climent C; Vélez R; Nazario CM; Díaz MV
P R Health Sci J; 2015 Jun; 34(2):89-92. PubMed ID: 26061059
[TBL] [Abstract][Full Text] [Related]
10. Her-2/neu oncogene expression in Puerto Rican females with breast cancer.
Peredo R; Sastre G; Serrano J; Hunter Mellado R
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1025-32. PubMed ID: 11785652
[TBL] [Abstract][Full Text] [Related]
11. Underuse of Radiation Therapy After Breast Conservation Surgery in Puerto Rico: A Puerto Rico Central Cancer Registry-Health Insurance Linkage Database Study.
Chance WW; Ortiz-Ortiz KJ; Liao KP; Zavala Zegarra DE; Stauder MC; Giordano SH; Tortolero-Luna G; Guadagnolo BA
J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241162
[TBL] [Abstract][Full Text] [Related]
12. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
[TBL] [Abstract][Full Text] [Related]
13. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
[TBL] [Abstract][Full Text] [Related]
14. Perinatal factors, female breast cancer, and associated risk factors in Puerto Rico: evidence from the Atabey epidemiology of breast cancer study.
Mattick LJ; Nazario CM; Rosario-Rosado RV; Schelske-Santos M; Mansilla-Rivera I; Ramírez-Marrero FA; Nie J; Freudenheim JL
Cancer Causes Control; 2022 Mar; 33(3):373-379. PubMed ID: 35000039
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Inflammatory Breast Cancer in Hispanic Women from Puerto Rico.
Quirindongo-Rivera C; Rullán-Varela V; Underill Z; Rivera M; Ortiz-Ortiz KJ; Martínez-Montemayor MM
J Cancer; 2022; 13(14):3495-3502. PubMed ID: 36484009
[No Abstract] [Full Text] [Related]
17. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
18. Triple negative breast cancer: a retrospective study of Hispanics residing in Puerto Rico.
Giraldo-Jiménez MY; Cabanillas F; Negrón V; Echenique M; Mojica P; Santiago K; Marcial V; Vaquer R; Carlo-Vargas V
P R Health Sci J; 2012 Jun; 31(2):45-51. PubMed ID: 22783695
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of HER-2 status in steroid receptor-positive, lymph node-negative breast carcinoma.
Peiró G; Adrover E; Aranda FI; Peiró FM; Niveiro M; Sánchez-Payá J
Am J Clin Pathol; 2007 May; 127(5):780-6. PubMed ID: 17439837
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
